Bilateral Mammary Artery Graft to Reduce the Chance of Repeat Revascularization

According to previous studies, patients receiving bilateral internal mammary artery conduits during coronary artery bypass grafting have better survival than those receiving a single internal mammary artery. The reason behind this remains unclear, let alone whether there really is lower repeat revascularization rate.

Doble puente mamario para reducir la chance de nuevas revascularizaciones

This analysis compared timing, frequency, and type of repeat coronary revascularization among patients receiving single vs. bilateral internal mammary artery conduits.


Read also: Myocardial Revascularization Surgery: One or Two Internal-Thoracic-Artery Grafts?”.


The study included 47,984 consecutive patients undergoing bypass revascularization surgery in 7 centers between 1992 and 2014. 1,482 of these patients received bilateral internal mammary artery conduits.

 

To compare them, patients were propensity matched, which left 1,297 patients in each branch (bilateral vs. single internal mammary artery) for final analyzis. Primary end point was freedom from repeat revascularization.


Read also: Additional Benefit from Radial Artery Graft in Myocardial Revascularization Surgery”.


After a 13.2 year follow up, well matched by age, comorbidities, ventricular function, etc., patients showed that bilateral internal mammary artery conduits are associated with higher freedom from revascularization, compared against single mammary artery conduits (HR= 0.78, CI 95%, 0.65 to 0.94; p=0.009). 19.4% (n=252) of patients in the single mammary artery branch required repeat revascularization at follow up vs. 15.1% (n=196) of patients with bilateral mammary artery conduits (p=0.004).

 

The vast majority of revascularization procedures were PCIs for both groups, the most frequently intervened being the right coronary and the circumflex.

 

In addition, bilateral internal mammary artery conduits were associated with a reduction in all-cause mortality at 12 years (HR, 0.79; p=0.001) and there was no increase in inhospital mortality rate.

 

Conclusion

Bilateral mammary artery conduits were associated with a reduction in repeat revascularization rate and better survival rate at long term, which is why it should be considered more frequently in myocardial revascularization surgery.

 

Editorial Comment

The NEJM has recently published the 5 year ART trial follow up, which randomized CABG patients to bilateral vs. single internal mammary artery grafts. This study, the largest on this matter, was not able to show differences at 5 years, though outcomes at 10 years remain pending. There was increased morbidity among patients receiving bilateral internal mammary artery grafts (sternal infections and need of sternal reconstruction).

 

Original title: Does Use of Bilateral Internal Mammary Artery Grafting Reduce Long-Term Risk of Repeat Coronary Revascularization? A Multicenter Analysis.

Reference: Alexander Iribarne et al. Circulation. 2017;136:1676–1685.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...